Sign in to view content

Two-Year Results From the Subretinal RGX-314 Gene Therapy Phase 1/2a Study for the Treatment of Neovascular AMD

Robert L. Avery, MD

Video
Published 2021

Related

Episode 16: PLACE Trial: Half-Dose PDT vs Micropulse Laser for Central Serous Chorioretinopathy with Dr. Camiel Boon
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
Chronical Submacular Hemorrhage in the Setting of Neovascular AMD
Rita Couceiro, MD, MS
carlos marques-neves, MD, PhD, EBO
Retina Image Bank: Images of the Week
2015
Patients Ultra-Responsive to Ranibizumab (RBZ): Rates of Great Than or Equal to 4-Step Improvement in Diabetic Retinopathy Severity in DRCR.net Protocol S
Allen Chiang, MD, FASRS
Annual Meeting Talks
2019

Category: AMD-Neovascular

See more